Drug Information
Side Effects > Xifaxan

Xifaxan Side Effects

Generic Name: Rifaximin

Please note - some side effects for Xifaxan may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).


For the consumer

For the professional

Side Effects of Xifaxan - for the consumer


Xifaxan

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Xifaxan:

Constipation; gas; headache; nausea; sensations of needing to empty the bowel; stomach pain; urgent bowel movements; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur when using Xifaxan:

Severe allergic reactions (rash; hives; itching; difficulty swallowing or breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; flushing); bloody stools; chest pain; fainting; severe diarrhea.

Top

For the professional


Xifaxan

The safety of Xifaxan™ Tablets 200 mg taken three times a day (TID) was evaluated in 320 patients in two placebo-controlled clinical trials with 95% of patients receiving at least three days of treatment with Xifaxan™ Tablets. All adverse events for Xifaxan™ Tablets 200 mg TID that occurred at a frequency ≥2% in the two placebo-controlled trials combined are provided in Table 2. (These include adverse events that may be attributable to the underlying disease.)


Table 2. All Adverse Events With an Incidence ≥2% Among Patients Receiving Xifaxan™ Tablets, 600 mg/day, in Placebo-Controlled Studies 
MedDRA Preferred Term Number (%) of Patients
Xifaxan™
Tablets,
600 mg/day
(N = 320)
Placebo
N = 228
Flatulence
36 (11.3%)
45 (19.7%)
Headache
31 (9.7%)
21 (9.2%)
Abdominal Pain NOS
23 (7.2%)
23 (10.1%)
Rectal Tenesmus
23 (7.2%) 20 (8.8%)
Defecation Urgency
19 (5.9%)
21 (9.2%)
Nausea
17 (5.3%)
19 (8.3%)
Constipation
12 (3.8%)
8 (3.5%)
Pyrexia
10 (3.1%) 10 (4.4%)
Vomiting NOS
7 (2.2%)
4 (1.8%)

The following adverse events, presented by body system, have also been reported in <2% of patients taking Xifaxan™ Tablets in the two placebo-controlled clinical trials where the 200 mg taken three times a day dose was used. The following includes adverse events regardless of causal relationship to drug exposure.

Blood and Lymphatic System Disorders: lymphocytosis, monocytosis, neutropenia

Ear and Labyrinth Disorders: ear pain, motion sickness, tinnitus

Gastrointestinal Disorders: abdominal distension, diarrhea NOS, dry throat, fecal abnormality NOS, gingival disorder NOS, inguinal hernia NOS, dry lips, stomach discomfort

General Disorders and Administration Site Conditions: chest pain, fatigue, malaise, pain NOS, weakness

Infections and Infestations: dysentery NOS, respiratory tract infection NOS, upper respiratory tract infection NOS

Injury and Poisoning: sunburn

Investigations: aspartate aminotransferase increased, blood in stool, blood in urine, weight decreased

Metabolic and Nutritional Disorders: anorexia, dehydration

Musculoskeletal, Connective Tissue, and Bone Disorders: arthralgia, muscle spasms, myalgia, neck pain

Nervous System Disorders: abnormal dreams, dizziness, migraine NOS, syncope, loss of taste

Psychiatric Disorders: insomnia

Renal and Urinary Disorders: choluria, dysuria, hematuria, polyuria, proteinuria, urinary frequency

Respiratory, Thoracic, and Mediastinal Disorders: dyspnea NOS, nasal passage irritation, nasopharyngitis, pharyngitis, pharyngolaryngeal pain, rhinitis NOS, rhinorrhea

Skin and Subcutaneous Tissue Disorders: clamminess, rash NOS, sweating increased

Vascular Disorders: hot flashes NOS

Postmarketing Experience

The following events: hypersensitivity reactions, including allergic dermatitis, rash, angioneurotic edema, urticaria, and pruritus; have been identified during foreign postapproval use of Xifaxan™ Tablets. Because these events are reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency or establish a causal relationship to drug exposure.

Top

More resources:

Drugs.com Xifaxan

PDR Xifaxan

MedFacts Xifaxan

Micromedex Xifaxan - Includes detailed dosage instructions.

FDA Xifaxan

Facts & Comparisons Rifaximin

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


MedNotes
Advertisement